Analysts Expect Sabra Health Care REIT Inc (SBRA) Will Announce Earnings of $0.62 Per Share

Brokerages expect Sabra Health Care REIT Inc (NASDAQ:SBRA) to post $0.62 earnings per share (EPS) for the current fiscal quarter, Zacks reports. Four analysts have provided estimates for Sabra Health Care REIT’s earnings. The lowest EPS estimate is $0.60 and the highest is $0.64. Sabra Health Care REIT posted earnings per share of $0.60 during the same quarter last year, which would suggest a positive year over year growth rate of 3.3%. The business is expected to announce its next quarterly earnings report on Wednesday, November 7th.

According to Zacks, analysts expect that Sabra Health Care REIT will report full-year earnings of $2.47 per share for the current year, with EPS estimates ranging from $2.39 to $2.51. For the next year, analysts forecast that the business will post earnings of $2.50 per share, with EPS estimates ranging from $2.31 to $2.62. Zacks’ earnings per share calculations are an average based on a survey of sell-side analysts that cover Sabra Health Care REIT.

Sabra Health Care REIT (NASDAQ:SBRA) last issued its quarterly earnings data on Wednesday, August 8th. The real estate investment trust reported $1.08 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.33 by $0.75. Sabra Health Care REIT had a return on equity of 11.21% and a net margin of 62.60%. The business had revenue of $166.31 million during the quarter, compared to analyst estimates of $166.62 million.

A number of equities analysts have weighed in on the company. ValuEngine downgraded Sabra Health Care REIT from a “sell” rating to a “strong sell” rating in a research report on Thursday, June 21st. BidaskClub raised Sabra Health Care REIT from a “buy” rating to a “strong-buy” rating in a research report on Saturday, June 23rd. Zacks Investment Research raised Sabra Health Care REIT from a “hold” rating to a “buy” rating and set a $25.00 price target for the company in a research report on Wednesday, July 11th. Jefferies Financial Group reaffirmed a “$21.91” rating and set a $22.00 price target on shares of Sabra Health Care REIT in a research report on Wednesday, July 18th. Finally, Mizuho reaffirmed a “buy” rating and set a $26.00 price target on shares of Sabra Health Care REIT in a research report on Monday, August 13th. One analyst has rated the stock with a sell rating, six have issued a hold rating and five have issued a buy rating to the company. The company presently has an average rating of “Hold” and a consensus target price of $22.73.

A number of large investors have recently added to or reduced their stakes in SBRA. Capital Fund Management S.A. bought a new stake in shares of Sabra Health Care REIT during the 2nd quarter worth approximately $2,169,000. OppenheimerFunds Inc. raised its stake in shares of Sabra Health Care REIT by 112.0% during the 2nd quarter. OppenheimerFunds Inc. now owns 68,422 shares of the real estate investment trust’s stock worth $1,487,000 after purchasing an additional 36,144 shares in the last quarter. Price Capital Management Inc. bought a new stake in shares of Sabra Health Care REIT during the 2nd quarter worth approximately $756,000. Bank of New York Mellon Corp raised its stake in shares of Sabra Health Care REIT by 0.5% during the 2nd quarter. Bank of New York Mellon Corp now owns 2,663,709 shares of the real estate investment trust’s stock worth $57,881,000 after purchasing an additional 12,607 shares in the last quarter. Finally, Standard Life Aberdeen plc bought a new stake in shares of Sabra Health Care REIT during the 2nd quarter worth approximately $507,000. 90.40% of the stock is owned by hedge funds and other institutional investors.

Shares of SBRA opened at $21.19 on Wednesday. The company has a debt-to-equity ratio of 1.00, a current ratio of 3.16 and a quick ratio of 3.16. Sabra Health Care REIT has a 52-week low of $15.77 and a 52-week high of $23.83. The company has a market capitalization of $4.12 billion, a P/E ratio of 8.72, a price-to-earnings-growth ratio of 2.74 and a beta of 0.62.

About Sabra Health Care REIT

As of June 30, 2018, Sabra's investment portfolio included 487 real estate properties held for investment (consisting of (i) 352 Skilled Nursing/Transitional Care facilities, (ii) 89 Senior Housing communities (?Senior Housing – Leased?), (iii) 24 Senior Housing communities operated by third-party property managers pursuant to property management agreements (?Senior Housing – Managed?) and (iv) 22 Specialty Hospitals and Other facilities), one asset held for sale, one investment in a direct financing lease, 22 investments in loans receivable (consisting of (i) one mortgage loan, (ii) two construction loans, (iii) one mezzanine loan, (iv) one pre-development loan and (v) 17 other loans), 13 preferred equity investments and one investment in an unconsolidated joint venture that owns 172 Senior Housing – Managed communities.

Further Reading: Leveraged Buyout (LBO) Explained

Get a free copy of the Zacks research report on Sabra Health Care REIT (SBRA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Sabra Health Care REIT (NASDAQ:SBRA)

Receive News & Ratings for Sabra Health Care REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Health Care REIT and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply